LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$4.31M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
14
New
Increased
Reduced
Closed

Top Buys

1
+$3.92M
2
+$1.4M
3
+$1.35M
4
GPCR icon
Structure Therapeutics
GPCR
+$547K
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$424K

Top Sells

1
+$3.07M
2
+$2.47M
3
+$1.64M
4
WHWK
Whitehawk Therapeutics
WHWK
+$831K
5
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$203K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$24.2M 20.18%
3,136,173
+10,000
2
$20.3M 16.92%
2,454,627
-371,349
3
$19.6M 16.38%
1,067,723
+213,132
4
$13.8M 11.54%
2,214,250
+215,833
5
$11.9M 9.96%
1,369,927
-283,568
6
$6.9M 5.75%
88,346
+17,989
7
$6.76M 5.64%
761,258
-22,900
8
$6.24M 5.2%
866,646
-227,254
9
$4.39M 3.66%
3,324,061
+320,959
10
$3.26M 2.72%
170,380
+2,584
11
$1.7M 1.42%
121,416
+6,859
12
$547K 0.46%
+23,000
13
$211K 0.18%
26,225
+900
14
– –
-64,739